Robust weights that optimally balance confounders for estimating marginal hazard ratios

TL;DR

This paper introduces robust orthogonality weights (ROW), a new method for covariate balancing in estimating marginal hazard ratios for time-to-event data, improving accuracy in observational studies involving treatments and confounders.

Contribution

The paper proposes ROW, a novel set of weights obtained through quadratic constrained optimization, specifically designed to balance covariates for hazard ratio estimation in survival analysis.

Findings

ROW improves covariate balance in simulations.

Application to Women's Health data shows effective treatment effect estimation.

Method outperforms existing weighting techniques in bias reduction.

Abstract

Covariate balance is crucial in obtaining unbiased estimates of treatment effects in observational studies. Methods based on inverse probability weights have been widely used to estimate treatment effects with observational data. Machine learning techniques have been proposed to estimate propensity scores. These techniques however target accuracy instead of covariate balance. Methods that target covariate balance have been successfully proposed and largely applied to estimate treatment effects on continuous outcomes. However, in many medical and epidemiological applications, the interest lies in estimating treatment effects on time-to-event outcomes. With this type of data, one of the most common estimands of interest is the marginal hazard ratio of the Cox proportional hazard model. In this paper, we start by presenting robust orthogonality weights (ROW), a set of weights obtained by solving a quadratic constrained optimization problem that maximizes precision while constraining covariate balance defined as the sample correlation between confounders and treatment. By doing so, ROW optimally deal with both binary and continuous treatments. We then evaluate the performance of the proposed weights in estimating marginal hazard ratios of binary and continuous treatments with time-to-event outcomes in a simulation study. We finally apply ROW on the evaluation of the effect of hormone therapy on time to coronary heart disease and on the effect of red meat consumption on time to colon cancer among 24,069 postmenopausal women enrolled in the Women's Health Initiative observational study.